Clinical Trial Update: Effect of Melatonin on Multiple Sclerosis Related Fatigue [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated melatonin for multiple sclerosis-related fatigue and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Fatigue | Phase 2 | Status: COMPLETED